课题基金 / 基金详情

Neuronal Tau-RNA interactions in health and disease

Neuronal Tau-RNA interactions in health and disease
健康和疾病中神经元 Tau-RNA 相互作用
批准号:
MR/Y012151/1
负责人:
Jernej Ule
金额:
$24.01万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2024
资助国家:
英国
项目状态:
未结题
起止时间:
2024 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neuronal dysfunction in Alzheimer's (AD) and related neurodegenerative diseases correlates with the aggregation of the microtubule associated protein Tau. Tau seems to induce a number of cellular changes that are mediated by disease-conditional interactions of Tau with other proteins, organelles, and RNA molecules. Moreover, Tau has a high affinity to RNA, and Tau:RNA interactions were shown to influence its canonical function in microtubule binding and promote its aggregation. The (patho)physiological role of Tau:RNA interactions remains understudied though. Our own preliminary data and published work show that Tau interacts with ribosomal and other non-coding RNAs (ncRNAs). Here, we aim to decipher the interactions of Tau with ncRNAs and determine their impact on ribosome function and chromatin regulation, processes that are altered in response to Tau. We will decipher neuronal Tau:RNA interactions in physiological versus pro-pathological stress conditions, study Tau:ncRNA interactions on the molecular level and determine the impact on key cellular processes, develop strategies to block abnormal Tau:ncRNA interactions, and explore the relevance of these findings for Tau biology in human neurons. The findings of this work will for the first time elucidate the role of ncRNAs in Tau (patho)biology and therefore have a large impact far beyond this proposal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
腹侧海马Calb1神经元tau蛋白聚集在阿尔茨海默样社交记忆障碍中的作用及机制研究
  • 批准号:
    JCZRQNB202600714
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
P2X7 受体调控小胶质细胞外泌体分泌参与阿尔茨海默病 tau 病理传播的过程及机制研究
  • 批准号:
    ZCLQN26C0901
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    赵帅
  • 依托单位:
基于多尺度MD和AI解析阿尔茨海默病Tau蛋白相分离失衡分子机制及靶向构象调控策略
  • 批准号:
    JCZRLH202600201
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
AEP剪切SET参与阿尔茨海默症Tau病变机制研究